首页> 外文期刊>BioMed research international >Novel Drugs Development for Cardio-/Cerebrovascular Diseases
【24h】

Novel Drugs Development for Cardio-/Cerebrovascular Diseases

机译:用于心脑血管疾病的新药开发

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Cardiovascular and cerebrovascular diseases are the leading causes of death worldwide. According to the current epi-demiological data, it is expected that, till 2020, coronary artery disease and cerebral hemorrhage are still the first and second causes of death of human beings, even though the order of the death causes due to human diseases would be changed significantly. Despite various advances in the understanding of the diseases, pharmacological treatment by conventional medicine has not obtained satisfactory results. However, recent studies suggest that natural products and traditional herbal medicine are a potential candidate for the preventative treatment of the disorders. Therefore, we have invited the researchers to contribute few research/review papers to provide solid evidence that supports the application of bioactives/traditional herbal medicine (THM) in prevention and treatment of cardiovascular and cerebrovascular diseases.
机译:心血管和脑血管疾病是世界范围内死亡的主要原因。根据目前的流行病学数据,预计到2020年,冠状动脉疾病和脑出血仍是人类死亡的第一和第二原因,即使人类疾病造成的死亡原因的顺序是变化很大。尽管在疾病的理解上有各种进步,但是常规医学的药物治疗仍未获得令人满意的结果。然而,最近的研究表明,天然产物和传统草药是预防疾病的潜在候选者。因此,我们邀请研究人员发表少量研究/评论论文,以提供有力的证据来支持生物活性物质/传统草药(THM)在心血管疾病和脑血管疾病的预防和治疗中的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号